Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 30 results.
User Information
Export Records
  1. 1.   Development of Neutralizing Antibodies against Zika Virus Based on Its Envelope Protein Structure
  2. Yang, Chunpeng; Gong, Rui; De Val Alda,Natalia
  3. Virologica Sinica. 2019, APR; 34(2): 168-174.
  1. 2.   Behavioral and Molecular Exploration of the AR-CMT2A Mouse Model Lmna (R298C/R298C)
  2. Poitelon, Y.; Kozlov, S.; Devaux, J.; Vallat, J. M.; Jamon, M.; Roubertoux, P.; Rabarimeriarijaona, S.; Baudot, C.; Hamadouche, T.; Stewart, C. L.; Levy, N.; Delague, V.
  3. Neuromolecular Medicine. 2012, Mar; 14(1): 40-52.
  1. 3.   SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses
  2. Lai, L. L.; Kwa, S. F.; Kozlowski, P. A.; Montefiori, D. C.; Nolen, T. L.; Hudgens, M. G.; Johnson, W. E.; Ferrari, G.; Hirsch, V. M.; Felber, B. K.; Pavlakis, G. N.; Earl, P. L.; Moss, B.; Amara, R. R.; Robinson, H. L.
  3. Vaccine. 2012, Feb; 30(9): 1737-1745.
  1. 4.   Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain
  2. Wexler-Cohen, Y.; Ashkenazi, A.; Viard, M.; Blumenthal, R.; Shai, Y.
  3. Faseb Journal. 2010, Nov; 24(11): 4196-4202.
  1. 5.   Friend Spleen Focus-Forming Virus Activates the Tyrosine Kinase sf-Stk and the Transcription Factor PU.1 to Cause a Multi-Stage Erythroleukemia in Mice
  2. Cmarik, J.; Ruscetti, S.
  3. Viruses-Basel. 2010, Oct; 2(10): 2235-2257.
  1. 6.   Assembly of the Murine Leukemia Virus Is Directed towards Sites of Cell-Cell Contact
  2. Jin, J.; Sherer, N. M.; Heidecker, G.; Derse, D.; Mothes, W.
  3. Plos Biology. 2009 7(7): 1 e1000163-15 e1000163.
  1. 7.   The Receptor Complex Associated with Human T-Cell Lymphotropic Virus Type 3 (HTLV-3) Env-Mediated Binding and Entry Is Distinct from, but Overlaps with, the Receptor Complexes of HTLV-1 and HTLV-2
  2. Jones, K. S.; Huang, Y. K.; Chevalier, S. A.; Afonso, P. V.; Petrow-Sadowski, C.; Bertolette, D. C.; Gessain, A.; Ruscetti, F. W.; Mahieux, R.
  3. Journal of Virology. 2009 83(10): 5244-5255.
  1. 8.   Intersubunit disulfide isomerization controls membrane fusion of human T-cell leukemia virus Env
  2. Li, K. J.; Zhang, S. J.; Kronqvist, M.; Wallin, M.; Ekstrom, M.; Derse, D.; Garoff, H.
  3. Journal of Virology. 2008 82(14): 7135-7143.
  1. 9.   Cell nuclei spin in the absence of lamin B1
  2. Ji, J. Y.; Lee, R. T.; Vergnes, L.; Fong, L. G.; Stewart, C. L.; Reue, K.; Young, S. G.; Zhang, Q. P.; Shanahan, C. M.; Lammerding, J.
  3. Journal of Biological Chemistry. 2007, Jul; 282(27): 20015-20026.
  1. 10.   Innate immune dysfunction in HIV infection: Effect of HIV envelope-NK cell interactions
  2. Kottilil, S.; Shin, K.; Jackson, J. O.; Reitano, K. N.; O'Shea, M. A.; Yang, J.; Hallahan, C. W.; Lempicki, R.; Arthos, J.; Fauci, A. S.
  3. Journal of Immunology. 2006, JAN 15; 176(2): 1107-1114.
  1. 11.   Friend spleen focus-forming virus transforms rodent fibroblasts in cooperation with a short form of the receptor tyrosine kinase Stk
  2. Nishigaki, K.; Hanson, C.; Jelacic, T.; Thompson, D.; Ruscetti, S.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2005, OCT 25; 102(43): 15488-15493.
  1. 12.   The nuclear envelope protein Man1 is required for angiogenesis in the embryonic yolk sac
  2. Cohen, T. V.; Stewart, C. L.
  3. Developmental Biology. 2005, JUL 15; 283(2): 602, Abstract 134-602, Abstract 134.
  1. 13.   Proteins that bind high-mannose sugars of the HIV envelope
  2. Botos, I.; Wlodawer, A.
  3. Progress in Biophysics and Molecular Biology. 2005, JUN; 88(2): 233-282.
  1. 14.   Cholesterol dependence of HTLV-I infection
  2. Wielgosz, M. M.; Rauch, D. A.; Jones, K. S.; Ruscetti, F. W.; Ratner, L.
  3. Aids Research and Human Retroviruses. 2005, JAN; 21(1): 43-50.
  1. 15.   Mechanisms of nonrandom human immunodeficiency virus type 1 infection and double infection: Preference in virus entry is important but is not the sole factor
  2. Chen, J. B.; Dang, Q.; Unutmaz, D.; Pathak, V. K.; Maldarelli, F.; Powell, D.; Hu, W. S.
  3. Journal of Virology. 2005 79(7): 4140-4149.
  1. 16.   Induction of human T cell leukemia virus type I receptors on quiescent naive T lymphocytes by TGF-beta(1,2)
  2. Jones, K. S.; Akel, S.; Petrow-Sadowski, C.; Huang, Y.; Bertolette, D. C.; Ruscetti, F. W.
  3. Journal of Immunology. 2005 174(7): 4262-4270.
  1. 17.   Disruption of spermatogenesis in mice lacking A-type lamins
  2. Alsheimer, M.; Liebe, B.; Sewell, L.; Stewart, C. L.; Scherthan, H.; Benavente, R.
  3. Journal of Cell Science. 2004 117(7): 1173-1178.
  1. 18.   Ex vivo and in vivo biological effects of a truncated form of the receptor tyrosine kinase Stk when activated by interaction with the friend spleen focus-forming virus envelope glycoprotein or by point mutation
  2. Rulli, K.; Yugawa, T.; Hanson, C.; Thompson, D.; Ruscetti, S.; Nishigaki, K.
  3. Journal of Virology. 2004 78(9): 4573-4581.
  1. 19.   The C- and the N-terminal regions of glycoprotein 41 ectodomain fuse membranes enriched and not enriched with cholesterol, respectively
  2. Shnaper, S.; Sackett, K.; Gallo, S. A.; Blumenthal, R.; Shai, Y.
  3. Journal of Biological Chemistry. 2004 279(18): 18526-18534.
  1. 20.   MICA and recovery from hepatitis C virus and hepatitis B virus infections
  2. Karacki, P. S.; Gao, X.; Thio, C. L.; Thomas, D. L.; Goedert, J. J.; Vlahov, D.; Kaslow, R.; Strathdee, S.; Hilgartner, M. W.; O'Brien, S. J.; Carrington, M.
  3. Genes and Immunity. 2004 5(4): 261-266.
  1. 21.   Molecular analysis of a recombinant M-MuLV/RaLV retrovirus
  2. Villanueva, R. A.; Campbell, S.; Roth, M. J.
  3. Virology. 2003 315(1): 195-208.
  1. 22.   Membrane fusion
  2. Blumenthal, R.; Clague, M. J.; Durell, S. R.; Ep, R. M.
  3. Chemical Reviews. 2003 103(1): 53-69.
  1. 23.   The synthetic peptide WKYMVm attenuates the function of the chemokine receptors CCR5 and CXCR4 through activation of formyl peptide receptor-like 1
  2. Li, B. Q.; Wetzel, M. A.; Mikovits, J. A.; Henderson, E. E.; Rogers, T. J.; Gong, W.; Le, Y.; Ruscetti, F. W.; Wang, J. M.
  3. Blood. 2001 97(10): 2941-2947.
  1. 24.   Vaccine protection against simian immunodeficiency virus by recombinant strains of herpes simplex virus
  2. Murphy, C. G.; Lucas, W. T.; Means, R. E.; Czajak, S.; Hale, C. L.; Lifson, J. D.; Kaur, A.; Johnson, R. P.; Knipe, D. M.; Desrosiers, R. C.
  3. Journal of Virology. 2000 74(17): 7745-7754.
  1. 25.   N36, a synthetic N-terminal heptad repeat domain of the HIV-1 envelope protein gp41, is an activator of human phagocytes
  2. Le, Y. Y.; Jiang, S.; Hu, J. Y.; Gong, W. H.; Su, S. B.; Dunlop, N. M.; Shen, W. P.; Li, B. Q.; Wang, J. M.
  3. Clinical Immunology. 2000 96(3): 236-242.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel